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CASE REPORTGiant cutaneous squamous cell carcinoma
requiring emergent embolization
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Cutaneous squamous cell carcinoma (cSCC), a
subset of nonmelanoma skin cancer (NMSC), is a
common form of skin malignancy. National cancer
registries have traditionally not tracked cSCC, but its
2012 incidence within the US white population was
estimated to be within 186,157 and 419,543.1 NMSCs
greater than 5 cm in size are labeled as giant NMSC.
These giant NMSCs usually arise owing to long-term
neglect of a slow-growing lesion and pose significant
challenges in treatment.2 Here, we present a case of a
giant cSCC in a 70-year-old woman that is unique in
several aspects, including its emergent presentation
and clinical features that made the cSCC standard
treatment impossible. We also describe the clinical
course of a novel treatment for cSCC: embolization of
the blood supply.
CASE REPORT
A 70-year-old white woman presented to the
University of Mississippi Medical Center emergency
department with uncontrolled bleeding from a large
malodorous head mass. According to the patient and
family, the mass appeared 1 year prior and progres-
sively increased in size. There were several other
small masses on her scalp that she self-treated with
needle drainage. She did not present for treatment
when the tumor initially appeared for fear of a cancer
diagnosis. She had intermittent headaches and visual
changes in the left eye for the 2 days prior to
presentation. Physical examination found a 12- 3
12-cm (Fig 1) bleeding fungating tumor occupying
50% of her left forehead, frontoparietal scalp, and
upper eyelid. The patient became hypotensive
with facial and conjunctival pallor secondary to
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ail: bbarlow@umc.edu.at that time was 6.8 g/dL with a hematocrit of 21.3%,
and we administered 2 units of packed red blood
cells. Application of pressure dressings infused with
lidocaine/epinephrine and electrocautery resulted
in hemostasis. An arteriogram showed a robust
vascular supply from the external carotid artery,
superficial temporal artery, and middle meningeal
artery and a small contribution from the occipital
artery (Fig 2). Interventional radiology achieved
embolization of the superficial temporal and medial
meningeal artery.
A computed tomography (CT) scan of the head
(Fig 3) found multiple scalp masses, the largest
measuring 12 cm in the greatest diameter with
underlying sclerosis of the left frontal bone
without bony invasion. A biopsy of the tumor
found cutaneous squamous cell carcinoma with
widespread necrosis (Fig 4). CT scan of chest,
abdomen, and pelvis found bilateral adrenal masses
measuring 2.4 cm and 2.6 cm of unknown etiology
and a cystic adnexal mass suspicious for ovarian
cystic lesion or neoplasm. The imaging found no
abnormalities suggestive of metastasis. American
Joint Committee on Cancer TNM staging for cSCC
classifies the tumor as T2,NX,M0, stage II cSCC.
The facial plastic surgery department was
consulted for evaluation. They recommended
against complete resection, as removing the tumor
would require excision of the left side of the fore-
head, underlying skull, left anterior skull, much ofJAAD Case Reports 2016;2:216-8.
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Fig 1. Photograph of giant cSCC on forehead of patient.
The tumor is positioned superior to her left eye.
Fig 2. CT angiogram of giant cSCC shows vascular supply.
Fig 3. Coronal CT of giant cSCC on forehead of patient.
Fig 4. Tumor biopsy shows cSCC with widespread
necrosis. (Original magnification: 3200.)
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to achieve clear margins. Additionally, palliative
debulking of the tumor posed a high risk of
uncontrollable bleeding because of the friability of
the tumor. Both procedures were deemed too high
risk to proceed, so palliative care, including radiation
and possible re-embolization, was recommended.
Because of her clinical condition, we did not seek
further workup of the ovarian mass.
The patient subsequently had cough and chest
pain, and a CT scan found subsegmental non-
occluding acute pulmonary emboli in both lungs.
The risk of anticoagulation was too great because of
her risk of bleeding from the tumor. We offered
insertion of an inferior vena cava filter, but the
patient refused the procedure, opting for hospice
care.
The patient presented 2 months later to the
neurosurgery department for a second embolization.
They performed diagnostic cerebral angiography,
which found substantial scalp and dural vessel
collateralization bypassing the previously embolizedvessels. Neurosurgery determined there was no
arterial supply substantial enough to achieve
satisfactory embolization.
We contacted the patient 6 months after the
attempted second embolization. She was living in
hospice care and receiving outpatient palliative
radiation therapy at a local hospital.DISCUSSION
This case describes an unusual presentation of a
giant cSCC with several unique features. Foremost,
the tumor was highly vascularized, leading to
significant treatment challenges. The tumor’s high
degree of vascularity precluded treatment with the
traditional therapy for cSCC, local surgical excision.3
Embolization of the vascular supply was the only
therapy administered during the initial admission.
Use of embolization to treat cutaneous tumors
was previously reported in 2 contexts: (1) as a
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intraoperative blood loss4,5 and (2) stabilization of
acute hemorrhage from congenital hemangiomas.6
In this case, because she was not a surgical
candidate, embolization was attempted as the
primary treatment rather than a pretreatment or
adjunct. Although the embolization was successful
in stabilizing the emergent hemorrhage, it was
ultimately ineffective at curing the disease because
of the rapid revascularization.
Because the patient decided against further
treatment of the primary tumor, it is difficult
to comment further on what therapies could
have improved her clinical condition. Although
embolization was effective in stabilizing her active
bleeding, it made little impact on the course of her
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